Key Entry Point for 'SARS-like' Virus Identified

SARS-like virus infects the body via a docking point in lung cells, says study.

Tests on lab cells have highlighted a key entry point for the new virus and suggest bats may be a natural reservoir for it, investigators said.

Severe Acute Respiratory Syndrome (SARS)
SARS is a viral respiratory disease caused by SARS-associated coronavirus.

The novel virus has been designated hCoV-EMC, meaning human coronavirus-Erasmus Medical Centre, after the Dutch health institution that spotted it.

First detected last year, it is a cousin of Severe Acute Respiratory Syndrome (SARS), which triggered a scare 10 years ago when it erupted in Southeast Asia, leaping to humans from an animal host.

But hCoV-EMC appears to be more lethal, killing nine out of 15 patients who have been treated for it in the Middle East and Britain. Multiple organ failure, especially the kidneys, has been a hallmark of the disease.

SARS-like Virus Kills 39-year-old Man in Saudi Arabia: WHO
A new victim in Saudi Arabia has succumbed to a SARS-like virus that has struck in Britain and the Middle East, bringing the global toll from the mystery illness to nine, WHO reports.

Reporting in the journal Nature, virologists at EMC said the virus latches onto a receptor called DPP4 on smooth cells in the airways.

The common pipistrelle bat shares the same receptor, they said.

Patient Dies from SARS-like Virus
In Britain, a person suffering from a SARS-like virus has died, report health officials, becoming the sixth death from the illness worldwide.

The finding points to bats as a natural source for the virus, although it is also theoretically possible that humans transmit the virus to bats, the study said.

And, the paper cautioned, it is also possible that other animal species act as an intermediary between bats and humans.

Have We Learnt Anything from SARS?
A highly contagious and deadly new illness sent people worldwide scrambling to cancel flights and schools were closed and sales of surgical masks spiked, a decade ago.

The discovery opens up pathways towards a potential vaccine or drug to combat hCoV-EMC, the researchers said.

In a commentary also carried by Nature, US microbiologists Tom Gallagher and Stanley Perlman said that on present evidence, hCoV-EMC "can be transmitted from human to human, (but) fortunately this seems to occur infrequently."

Further work should determine whether the disease "is truly rare and always severe, or alternatively, is widespread but generally mild and therefore not detected."

Source-AFP